
What happens when a physician becomes the victim of medical gaslighting? They almost die. In a recent episode of The Podcast by KevinMD, neurologist Dr. Carolyn Larkin Taylor shared a story that exposes a massive crack in our medical system. Dr. Taylor went to her gynecologist of 20 years with postmenopausal bleeding. Her doctor, who was days away from retiring and closing her practice, was too busy to investigate properly. Instead of referring her out or doing the necessary procedures, she told Dr. Taylor her symptoms were "just stress" and told her to come back in a year. Dr. Taylor is a physician. She knew she wasn't stressed. She listened to her intuition, sought care at an academic institution, and was immediately diagnosed with endometrial cancer. If she had waited that year, she likely would not have survived. Medical gaslighting is an epidemic, particularly for women and the elderly. Dr. Taylor points out that this is rarely born out of malice. It comes from a broken culture. Doctors are severely crunched for time, buried in electronic medical records, and exhausted. When they cannot figure out a complex problem quickly, it is far too easy to dismiss the patient as anxious or stressed. But the subtle nonverbal cues like a sigh, a smirk, or a rushed exit make patients feel small. It makes them stop asking questions. We have to change this dynamic. Patients: Your intuition is valid. If you feel a whisper in your mind that something is wrong, do not ignore it. Demand a second opinion. Physicians: We must remember the power of our words and our body language. It is okay to say "I do not know, let me refer you to someone who might." We have to bridge the gap between curing and healing. You can find the link to this recent episode in the comments. It is a must-listen for both medical professionals and patients. #MedTwitter #MedicalGaslighting #PatientAdvocacy #Healthcare #WomensHealth #KevinMD #PhysicianBurnout #MedEd

An intriguing case of “exceptional resilience” against dementia A 75-year-old man free of dementia despite a dominant Alzheimer’s mutation — and a possible hint for the rest of us https://t.co/lWn9gCKrEm https://t.co/jq0L2NtZ27
I mean…(allegedly) the hospital executives at a local Childrens hospital got $250k BONUSES each. It’s a nonprofit hospital. Many nonprofit hospital executives get paid millions a year. I guess the numbers just don’t shock me anymore.
A short video of a man picking up his wife a Dr who just completed 36 hours of straight call prompted netizens to urge KKM to improve working conditions. It reminded me of my housemanship days way back in 1990 in...

I teach medical students about neurodegeneration. But a new clinical trial shows the most powerful brain drug might be free. Researchers at AdventHealth put 130 adults (ages 26-58) through a randomized controlled trial: 150 minutes of aerobic exercise per week vs....
The “root cause” is a dysregulated appetite with a terrible environment. The GLP-1 normalizes the dysregulated appetite and allows for navigation of the environment.

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://t.co/Jq8Zh6XQlY https://t.co/OFicPSvJuH
"The Iran War Is Creating a Public Health and Environmental Crisis" by @thor_benson for @RollingStone (via @YahooNews): https://t.co/bAYYyScmwJ
Big Pharma isn't in the business of making us healthy, they're in the business of keeping us on meds.
Most women don't realize that blood sugar issues can shut down ovulation. When insulin stays elevated, it suppresses something called SHBG, which means too much free testosterone begins to circulate. That excess testosterone interferes with follicle development and can stop the...

Health Canada recommends limiting alcohol to just 2 drinks per week 🍷(In case you missed it, since 2023) https://t.co/44vxHDboSx https://t.co/hkhxyFe8fi
Sometimes I feel like a tin hat but I also studied in a field that focuses on the interconnected nature of systems and how these systems impact health And then I worked in policy, understanding how decisions are made about...

Nice piece @axios by @caitlinnowens on the use of AI by docs for diagnosis. She describes her mom's amyloid (rare & oft-missed multisystem illness) misdiagnosis. I'm not 100% sure AI would have helped, but it does have some unique skills...
A great discussion by the brilliant @AdamRodmanMD on the new study of @Google 's AMIE (medical AI) tool, including the study's limitations. Bottom line is the tool's performance is impressive and getting better, but it's still best thought of as...
When I came off birth control after 13 years, I expected my period to come back within a month or two. It took 3.5 years. Most doctors will tell you your cycle should return within 3 months. For some women...
AI: Short-Term Cliffs (0-3 years remaining): Drugs like sacubitril/valsartan, dapagliflozin, pembrolizumab, ocrelizumab, daratumumab, and apixaban face imminent generic/biosimilar pressure Mid-Term Protection (4-7 years): Risankizumab and dupilumab have solid runway, supported by ongoing label expansions. Long-Term (8+ years): Tirzepatide's robust patents position it...

Another big Epic litigation update, as Judge Fillmore denied Epic's Motion to Dismiss in full in Texas v. Epic. It’s a loss, but somewhat of an expected one, as the state specific 91a pleading standard is a low bar. https://t.co/S9eI9qwFOV
These micro-cages are designed to hold and manipulate tiny cell clusters in miniaturized lab-on-a-chip devices. https://spectrum.ieee.org/lab-on-a-chip-grippers?share_id=9241061
The first human age-reversal trial is officially happening. But before the FDA cleared it, Harvard professor David Sinclair had to pull off a mice experiment most scientists thought was impossible: "These mice had their optic nerve regenerated. We were able to...
New York wants to ban AI that outscores doctors on medical exams. Over 900,000 New Yorkers have no insurance. 92% of low-income legal problems go unaddressed. Anti-AI NY bill S7263 isn't consumer protection. It's cartel protection. https://t.co/e9BdWuvvUB
SleepFM is a multimodal #AI foundation model for disease prediction. Developed by @Stanford researchers, trained on over 585K hours of polysomnography (PSG) data from 65K patients. It analyzes brain, heart, & respiratory signals to predict 130+ diseases—including dementia, cancer, and heart...

So proud to be on stage again with Serena at the ATOM event in LA talking to our dear friends Vartan Sarkissian and his father President Armen Sarkissian of Armenia 🇦🇲 about the future of medicine and healthcare 🧬 ATOM...
Wait? How is this possible. That would be 1 in 6 people are on a hospital waiting list? It's criminal how bad this countries health service is given we've had record tax income.

Rates of Influenza and Pneumococcal Vaccination and Correlation with Survival in Multiple Myeloma Patients [Dec 6, 2022] @mtmdphd et al. @AjaiChari CLML https://t.co/kUQeRmdKWV #NCT02761187 #mmsm #IDonc #ClinicalTrials #caxtx https://t.co/L7r9caCcGN

MT @hhashmi87 #IMS25 Great Meet The Expert talk by @bdermanmd on MRD in Myeloma Risk vs benefit Who can stop treatment Active surveillance post discontinuation #mmMRD #mmsm https://t.co/YOBOPs7hQL
Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) - @bdermanmd et al. @ajjakubowiak #ASCO24 Abstract 106 https://t.co/FBTY7SnCxK #NCT04108624 #mmsm #mmMRD

Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol https://t.co/8zhxYfYwZQ #mmsm #mmMRD https://t.co/QTlR2gv5Q0

#mmMRD healthcare social media hashtag [Nov 21, 2020] Minimal/measurable residual disease (MRD) in multiple myeloma. Submitted by @bdermanmd to @symplur @healthhashtags https://t.co/grkkiox2yh #mmsm No longer available at Symplur https://t.co/IGDrNALHBP
Consumption of coffee and tea and the risk of developing neurodegenerative diseases: a cohort study in the UK biobank https://t.co/bv0q79xKni
A hospital room can feel very small. But the mind doesn’t have to stay there. At Cedars-Sinai, we’re using VR to help patients explore beautiful places beyond the four walls of the hospital room. Not to escape life… but to contemplate its beauty in...
Six years ago today, on Friday, March 13, 2020, I sent the email switching all my clients to telehealth. Some of them didn’t want to do online sessions; they said they’d rather wait a little, until things blew over. I...
AI will likely report most X-rays near-autonomously within 3–5 years. We may soon have AI generating reports instantly… while radiologists still wait for the RIS loading wheel to open them.
Research SF’s drug crisis is like trying to fight a fire and finding out a bunch of laws passed that make using water to fight fires illegal. Then having to research non-water based solutions to large scale fires.

New MPO article by Lisa Anderson: From Reactive to Proactive: planning strategies for Medtech customer and margin success. Ready to move from firefighting to proactive planning? Contact LMA. #MedTech #SIOP #SupplyChain https://t.co/6Kr0hpMRaq

Robots’ potentials have been a fascination for humans and have even led to a booming field of robot-assisted surgery. Surgical robots assist surgeons in performing accurate, minimally invasive procedures that are beneficial for patients’ recovery. The assistance of robots extend beyond incisions...

The longer we live, the more the cancer odds go against us. So it is a race between medicine and aging. More on this in the Chartbook Top Links today. https://t.co/RpUy2t9fij
Class-action lawsuit claims Epic’s MyChart fragments patient records across portals, blocking full access & delaying disability claims. True interoperability still a challenge in digital health. https://t.co/jiKal8ggTl #DigitalHealth
HEARING $UHS --negative call out right now- CMS has delayed Florida Direct payment approval due to CMS concerns-- capital forum confirmed

Great to see ophthlamologists adopting epigenetic modifications and resets to treat eye diseases like glaucoma. A paradigm shift in medicine https://t.co/g2gr3WVpkf https://t.co/6gbBVHJuXI
Congressional advisers call to rein in Medicare Advantage spending amid industry pressure I’ll summarize for you. EVERY SINGLE FAMILY IN THE USA IS PAYING $800 A YEAR to the big insurance companies because taxpayers pay them more than it...
I’ve been an orthopedic surgeon for nearly 30 years, and a few patterns have become impossible to ignore. One is that many musculoskeletal problems in adults aren’t sudden injuries. They’re the moment when declining capacity and awful metabolic health finally...
With FDA go ahead, a China #biotech notches a first in cell therapy testing https://t.co/QorwJmou8w by @realJacobBell $XENE $BHVN

1. #Measles update: The total confirmed cases so far this year has risen to 1362 as of 3/12. Key context: The 2026 total to date is 60% of the 2025 total for the entire year. #CDC reports that among cases with...

Cancer vaccines are showing marked efficacy vs refractory cancers and are going to be part of the future Rx armamentarium. Beyond that, ultimately, for prevention in high-risk individuals. A new stellar review @NatureMedicine https://t.co/PhtdZDtSBl https://t.co/okmwCD8AyB
Lasting improvement doesn’t come from dashboards or mandates. It comes from clinicians who trust the data and own the change. A great conversation on what really works. 👉 https://t.co/SwV5qc59SV @HealthCatalyst #clinicalimprovement #HITSM
It is not clear to me how denying diagnosis to adults like me would get children more medical help.

100 brain microhemorrhages in a patient with cerebral amyloid angiopathy and 2 copies of APOE4 after amyloid antibody therapy https://t.co/ASpVuijFNW https://t.co/hdtwtv1usq
NEW: Another failure in the clinic in the world of LAG-3, a target once seen as possibly the next major checkpoint inhibitor after PD-1 and CTLA-4. My latest on Immutep's Phase 3 disappointment, as LAG-3 focus now shifts to a...
@angelazhay - I'd be keen to make contact with you to discuss NHS waiting lists for a piece I'm working on. Could you reach me on laura.donnelly@telegraph.co.uk?

Peptide therapeutics are powerful. But making them has always been difficult. Traditional chemical synthesis can involve long routes, poor selectivity, and significant environmental impact, while biological production is often limited by the pathways evolution happened to provide. What if we could design...